Ascendis Pharma A/S
Ascendis Pharma A/S (ASND) Covered Calls
As of September 21, 2026, ASND has 82 covered call opportunities in the coming three months. Return ranges from 4.2 to 79.5% until expiration. Annualized return ranges from 16.4 to 228.5%. The nearest expiration is October 16, 2026. Maximum potential profit is $18,828.
Read more
Running ASND covered calls helps you generate consistent income from Ascendis Pharma A/S's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Ascendis Pharma A/S involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best ASND covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if ASND stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling ASND covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Ascendis Pharma A/S covered call is worth writing.
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.
Income-focused investors, long-term ASND holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling ASND covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Ascendis Pharma A/S covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile4.76% Subdued
- Market cap (M$)15,603
- 52 weeks high-15.79%
- 52 weeks low27.70%
- Analyst recommendationStrong Buy
1.10 - Target price$311.56
31.13% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-11
- P/E18.10
- Future P/E22.83
- EPS (ttm)13.12
- EPS growth next 5 years—
As of September 21, 2026
| 2026-11-20 | 63 | 330.00 | 39.41 | 0.10 | 3.10 | 9338.00 | 39.45 | 228.54 | -0.04 | +0.08 | 1 | 3.00 |
| 2027-01-15 | 119 | 400.00 | 68.98 | 0.05 | 0.80 | 16333.00 | 69.00 | 211.63 | -0.02 | +0.02 | 0 | 0.75 |
| 2026-11-20 | 63 | 320.00 | 35.18 | 0.30 | 1.50 | 8358.00 | 35.31 | 204.56 | -0.13 | +0.05 | 1 | 1.20 |
| 2026-10-16 | 28 | 270.00 | 14.06 | 0.60 | 1.90 | 3388.00 | 14.31 | 186.57 | -0.25 | +0.11 | 270 | 1.30 |
| 2026-12-18 | 91 | 330.00 | 39.41 | 0.35 | 3.20 | 9363.00 | 39.55 | 158.65 | -0.15 | +0.08 | 258 | 2.85 |
| 2027-01-15 | 119 | 350.00 | 47.85 | 0.20 | 3.40 | 11348.00 | 47.94 | 147.04 | -0.08 | +0.08 | 129 | 3.20 |
| 2026-12-18 | 91 | 320.00 | 35.18 | 0.50 | 3.70 | 8378.00 | 35.39 | 141.96 | -0.21 | +0.10 | 93 | 3.20 |
| 2026-11-20 | 63 | 290.00 | 22.51 | 0.55 | 4.80 | 5383.00 | 22.74 | 131.75 | -0.23 | +0.14 | 0 | 4.25 |
| 2026-10-16 | 28 | 260.00 | 9.83 | 0.40 | 3.90 | 2368.00 | 10.00 | 130.40 | -0.17 | +0.18 | 138 | 3.50 |
| 2026-12-18 | 91 | 310.00 | 30.96 | 0.35 | 4.50 | 7363.00 | 31.10 | 124.76 | -0.15 | +0.11 | 28 | 4.15 |
As of September 21, 2026
Sell covered calls with the data behind you
Find the best ASND covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→